Tricida Announces Submission of New Drug Application for Veverimer for the Treatment of Metabolic Acidosis in Patients with Chronic Kidney Disease by Seini Moimoi | Sep 4, 2019 | Portfolio News
SutroVax Receives CARB-X Award for Up to $15 Million to Develop a Universal Vaccine to Prevent Group A Streptococcus Infections by Seini Moimoi | Sep 3, 2019 | Portfolio News
Akebia Therapeutics Announces Full Enrollment of its Global Phase 3 Program of Vadadustat for the Treatment of Anemia Due to Chronic Kidney Disease by Seini Moimoi | Sep 3, 2019 | Portfolio News
Aptinyx Presents Data Demonstrating Positive Activity of NYX-458 on Cognitive Performance and Biomarkers in a Preclinical Model of Head Injury by Seini Moimoi | Aug 21, 2019 | Portfolio News
Aimmune Enrolls First Patient in Phase 2 Trial of AR201 for Egg Allergy by Seini Moimoi | Aug 21, 2019 | Portfolio News
